Aimei Health Technology Co., Ltd
NASDAQ:AFJKShell Companies
-$3.66 today
- Market cap
- $73.22M
- Beta
- 0.23
- P/E (TTM)
- 34.3
- EPS (TTM)
- $0.88
Volume 0.13M
Average 0.02M
AFJK Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Aimei Health Technology Co., LtdNASDAQ: AFJK
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents rises 152.1% from a year ago
Cash & equivalents stood at $18.52K at the end of Q1 FY2026, up 152.1% from a year earlier and up 532.2% from the prior quarter.
Context
- Cash & equivalents amounted to 0.2% of total assets at the end of Q1 FY2026, up 0.1 pp from a year earlier.
- Cash & equivalents increased in 0 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +152.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 2.93K USD
- Year-over-year change
- -89.6%
- 2-year CAGR
- -92.9%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.93K | -89.6% |
| FY2024 | 2024-12-31 | 28.21K | -95.1% |
| FY2023 | 2023-12-31 | 580.72K | — |
Cash & Equivalents vs competitors
How AFJK compares with its peers on the latest reported figures
- AFJK's Mar 2026 cash & equivalents of $18.52K is the 6th highest of the 8 companies compared; the peer median is $151.62K.
- Its year-over-year change of +152.1% is the 2nd highest of 7, against a peer median of -30.9%.
- Cash & equivalents amounts to 0.2% of total assets for AFJK, versus a peer median of 0.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Dec 2025 | $7.73M | +24.5% | — | 1.4% | |
KOYNCSLM Digital Asset Acquisition Corp III Class A Ordinary Shares | Mar 2026 | $2.8M | +11108.6% | — | 1.2% |
ORIQUOrigin Investment Corp I Units | Mar 2026 | $834.11K | — | — | 1.1% |
EURKEureka Acquisition Corp Class A Ordinary Share | Mar 2026 | $151.62K | -57.3% | — | 0.5% |
| Mar 2026 | $50.19K | -4.6% | — | 0.4% | |
AFJKAimei Health Technology Co., Ltd | Mar 2026 | $18.52K | +152.1% | — | 0.2% |
UYSCUY Scuti Acquisition Corp. | Dec 2025 | $8.85K | -93.9% | — | 0.0% |
| Mar 2026 | $1.88K | -99.6% | — | 0.0% | |
| Peer median (excluding AFJK) | $151.62K | -30.9% | — | 0.5% | |
Competitors are the stored peer set for AFJK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Cash & Equivalents | 580.72K | 28.21K | 2.93K |
| Short-term Investments | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 |
| Total Current Assets | 580.72K | 30.38K | 2.93K |
| Property, Plant & Equipment (Net) | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 |
| Long-term Investments | 69.89M | 73.78M | 12.1M |
| Tax Assets | 0 | 0 | 0 |
| Other Non-current Assets | (1) | 0 | 0 |
| Total Non-current Assets | 69.89M | 73.78M | 12.1M |
| Total Assets | 70.47M | 73.81M | 12.1M |
| Account Payables | 0 | 0 | 0 |
| Short-term Debt | 0 | 227.7K | 2.02M |
| Tax Payables | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 |
| Total Current Liabilities | 24.84K | 816.99K | 3.37M |
| Long-term Debt | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 |
| Other Non-current Liabilities | 690K | 690K | 690K |
| Total Non-current Liabilities | 690K | 690K | 690K |
| Total Liabilities | 714.84K | 1.51M | 4.06M |
| Common Stock | 69.89M | 73.78M | 12.1M |
| Retained Earnings | (134.34K) | (1.48M) | (4.06M) |
| Accumulated OCI | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| Total Equity | 69.76M | 72.31M | 8.04M |
| Total Debt | 0 | 227.7K | 2.02M |
| Net Debt | (580.72K) | 199.49K | 2.02M |
Aimei Health Technology Co., Ltd
NASDAQ:AFJK
Intrinsic Alpha fair value
Locked
Current Price
$11.96
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.